![dual glp-1/gip agonist The Sustained Effects of a GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes: Cell Metabolism PDF] Novel dual GLP-1/GIP receptor](https://www.cell.com/cms/attachment/2119340205/2092424974/fx1.jpg)
dual glp-1/gip agonist The Sustained Effects of a GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes: Cell Metabolism PDF] Novel dual GLP-1/GIP receptor
Description
Severe nausea, vomiting, or dizzinessseek immediate help
![dual glp-1/gip agonist The Sustained Effects of a GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes: Cell Metabolism PDF] Novel dual GLP-1/GIP receptor](https://figures.semanticscholar.org/d83a64f6b7193358c31030487761fc19c80dd33c/3-Figure1-1.png)
GLP-1 RAs, such as semaglutide and tirzepatide, may also help improve metabolic health in patients with PCOS by promoting weight loss, improving insulin sensitivity, and reducing blood glucose levels ( 4 , 6 , 14 )
![dual glp-1/gip agonist The Sustained Effects of a GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes: Cell Metabolism PDF] Novel dual GLP-1/GIP receptor](https://bodyworkstn.com/wp-content/uploads/2026/04/glp1-vs-dual-mechanism-v2.png)
Information sourced from: GLP-1 diabetes and weight-loss drug side effects: Harvard Health
![dual glp-1/gip agonist The Sustained Effects of a GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes: Cell Metabolism PDF] Novel dual GLP-1/GIP receptor](https://cdn2.caymanchem.com/cdn/cms/caymanchem/PublishingImages/Lists/NewsItems/AllItems/Summary%20of%20insulin%20and%20glucagon%20pathways%20in%20glucose%20homeostasis.png)
Ozempic and Wegovy are the same active ingredient (semaglutide), at different doses for different indications
![dual glp-1/gip agonist The Sustained Effects of a GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes: Cell Metabolism PDF] Novel dual GLP-1/GIP receptor](https://ars.els-cdn.com/content/image/1-s2.0-S2212877821000211-gr1.jpg)
The study was conducted in 19951996, and we used commercially available synthetic, human GLP-1 (736 amide) [6]
![dual glp-1/gip agonist The Sustained Effects of a GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes: Cell Metabolism PDF] Novel dual GLP-1/GIP receptor](https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/fa96323e992666b739d78b6b7ef8194ddf36b506-1066x722.png/Screenshot%202024-03-07%20at%2011.56.15%E2%80%AFAM.png?w=1066&max-h=722&fit=crop&auto=format)
doi: 10.1097/ALN.0000000000005174
![dual glp-1/gip agonist The Sustained Effects of a GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes: Cell Metabolism PDF] Novel dual GLP-1/GIP receptor](https://www.researchgate.net/publication/356509652/figure/fig1/AS:1093898810204200@1637817208954/Main-physiological-actions-of-the-dual-GIP-and-GLP-1-agonist-tirzepatide.png)
